Methyl tert-butyl ether structure
|
Common Name | Methyl tert-butyl ether | ||
---|---|---|---|---|
CAS Number | 1634-04-4 | Molecular Weight | 88.148 | |
Density | 0.8±0.1 g/cm3 | Boiling Point | 55.2±0.0 °C at 760 mmHg | |
Molecular Formula | C5H12O | Melting Point | -110 °C | |
MSDS | Chinese USA | Flash Point | -10.0±0.0 °C | |
Symbol |
GHS02, GHS07 |
Signal Word | Danger |
Name | methyl tert-butyl ether |
---|---|
Synonym | More Synonyms |
Density | 0.8±0.1 g/cm3 |
---|---|
Boiling Point | 55.2±0.0 °C at 760 mmHg |
Melting Point | -110 °C |
Molecular Formula | C5H12O |
Molecular Weight | 88.148 |
Flash Point | -10.0±0.0 °C |
Exact Mass | 88.088814 |
PSA | 9.23000 |
LogP | 1.15 |
Vapour density | 3.1 (vs air) |
Vapour Pressure | 251.3±0.1 mmHg at 25°C |
Index of Refraction | 1.375 |
Storage condition | −20°C |
Stability | Stable, but may form explosive peroxides in contact with air. Extremely flammable - note low flash point. Incompatible with strong oxidizing agents. |
Water Solubility | 51 g/L (20 ºC) |
Freezing Point | -108.6℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS02, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H315 |
Precautionary Statements | P210 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US) |
Hazard Codes | F:Flammable |
Risk Phrases | R11;R38 |
Safety Phrases | S9-S16-S24-S45-S36/37 |
RIDADR | UN 2398 3/PG 2 |
WGK Germany | 3 |
RTECS | KN5250000 |
Packaging Group | II |
Hazard Class | 3 |
HS Code | 2909199090 |
Precursor 10 | |
---|---|
DownStream 9 | |
HS Code | 2909199090 |
---|---|
Summary | 2909199090. other acyclic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters.
Cancer Chemother. Pharmacol. 75(2) , 281-91, (2015) Despite overall successful application to multiple myeloma patients, clinical efficacy of the proteasome inhibitor bortezomib is typically challenged by primary and secondary resistance of unknown ori... |
|
Mechanistic Scrutiny Identifies a Kinetic Role for Cytochrome b5 Regulation of Human Cytochrome P450c17 (CYP17A1, P450 17A1).
PLoS ONE 10 , e0141252, (2015) Cytochrome P450c17 (P450 17A1, CYP17A1) is a critical enzyme in the synthesis of androgens and is now a target enzyme for the treatment of prostate cancer. Cytochrome P450c17 can exhibit either one or... |
|
Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
J. Steroid Biochem. Mol. Biol. 152 , 142-54, (2015) Androsta-1,4,6-triene-3,17-dione (ATD) is an irreversible steroidal aromatase inhibitor and is marketed as a supplement. It has been reported to effectively reduce estrogen biosynthesis and significan... |
Propane, 2-methoxy-2-methyl- |
methyl t-butyl ether |
Methyl tert-butyl ether |
ARCOPURE(R) MTBE |
tert-BuOCH3 |
tert-butylmethyl ether |
MTBE |
Methyl tertiary-butyl ether |
EINECS 216-653-1 |
MBT-ETHER |
tert-butyl methyl ether |
Methyl -butyl ether |
Driveron |
methyl-t-butyl ether |
(CH3)3COCH3 |
BOC-L-ARG(MTR)-OH |
tert-butyl-methyl-ether |
TBME |
tert-C4H9OCH3 |
2-methoxy-2-methyl |
2-Methoxy-2-methylpropane |
HP-MTBE |
t-butyl methyl ether |
MFCD00008812 |
Methyl 1,1-dimethylethyl ether |
MTBE,Methyl tert-butyl ether |
Ether, tert-butyl methyl |
methyl-tert-butyl ether |
MTB |